|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Warfarin sensitivity related to CYP2C9,CYP3A5,ABCB1 (MDR1) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O Karlsson J Yue QY Magnusson PK | 2004 | Pharmacogenomics J2004，4，： | 1 |
| 2 | Warfarin sensitivity related to CYP2C9 ,CYP3A5 ,ABCB1 ( MDR1 )and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 3 | Warfarin sensitivity related to CYP2C9,CYP3A5,ABCB1 (MDR1) and other factors显示文摘 | Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 4 | Wartarin sensitivity related to CYP2C9, CYP3A5, ABCB1 ( MDR1 ) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 5 | Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDRI) and other factors 显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 6 | Warfarin sensitivity related to CYP2C9, CYP3AS, ABCB1 (MDR1) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 7 | Warfarin sensitivity related to CYP2C9,CYP3A5,ABCB1 (MDR1) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | | 0，，01： | 1 |
| 8 | Warfarin sensitivity related to CYP2C9, CYP3A5, ABCBI ( MDR1 ) and other factors 显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 9 | Warfarin sen- sitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomics J2004，4，1： | 1 |
| 10 | Warfarin sensitivity re- lated to CYP2C9, CYP3A5 ,ABCB1 ( MDR1 ) and other factors显示文摘 | Wadelius M Sorlin K Wallerman O | 2004 | Pharmacogenomies J2004，4，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员